Manuscripts and Publications

Filters: First Letter Of Last Name is G  [Clear All Filters]
Publication
Mabragaña M, Carballo-Diéguez A, Giguere R.  2013.  Young women's experience with using videoconferencing for the assessment of sexual behavior and microbicide use.. Telemed J E Health. 19(11):866-71.
Hill BJ, Motley DN, Rosentel K, VandeVusse A, Garofalo R, Kuhns LM, Kipke MD, Reisner S, Rupp B, Goolsby RWest et al..  2020.  Work2Prevent, an Employment Intervention Program as HIV Prevention for Young Men Who Have Sex With Men and Transgender Youth of Color (Phase 3): Protocol for a Single-Arm Community-Based Trial to Assess Feasibility and Acceptability in a Real-World Settin. JMIR Res Protoc. 9(9):e18051.
Hill BJ, Motley DN, Rosentel K, VandeVusse A, Garofalo R, Kuhns LM, Kipke MD, Reisner S, Rupp B, Goolsby RWest et al..  2020.  Work2Prevent, an Employment Intervention Program as HIV Prevention for Young Men Who Have Sex With Men and Transgender Youth of Color (Phase 3): Protocol for a Single-Arm Community-Based Trial to Assess Feasibility and Acceptability in a Real-World Settin. JMIR Res Protoc. 9(9):e18051.
Savel C, Mierzwa S, Gorbach P, Lally M, Zimet G, Meyer K, Souidi S, Interventions A.  2014.  Web-based, mobile-device friendly, self-report survey system incorporating avatars and gaming console techniques.. Online J Public Health Inform. 6(2):e191.
Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, D Harris R et al..  2018.  Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial.. Clin Infect Dis. 66(2):220-228.
Havens PL, Hazra R, Stephensen CB, Kiser JJ, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR et al..  2014.  Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate.. Antivir Ther. 19(6):613-8.
Giguere R, Carballo-Diéguez A, Ventuneac A, Mabragaña M, Dolezal C, Chen BA, Kahn JA, Zimet GD, McGowan I.  2012.  Variations in microbicide gel acceptability among young women in the USA and Puerto Rico.. Cult Health Sex. 14(2):151-66.
W Comulada S, Goldbeck C, Almirol E, Gunn HJ, Ocasio MA, M Fernández I, Arnold EMayfield, Romero-Espinoza A, Urauchi S, Ramos W et al..  2021.  Using Machine Learning to Predict Young People's Internet Health and Social Service Information Seeking.. Prev Sci. 22(8):1173-1184.
W Comulada S, Goldbeck C, Almirol E, Gunn HJ, Ocasio MA, M Fernández I, Arnold EMayfield, Romero-Espinoza A, Urauchi S, Ramos W et al..  2021.  Using Machine Learning to Predict Young People's Internet Health and Social Service Information Seeking.. Prev Sci. 22(8):1173-1184.
Gamarel KE, Nelson KM, Brown L, M Fernández I, Nichols S.  2017.  The Usefulness of the CRAFFT in Screening for Problematic Drug and Alcohol Use Among Youth Living with HIV.. AIDS Behav. 21(7):1868-1877.
Geanuracos CG, Cunningham SD, Weiss G, Forte D, Reid LMHenry, Ellen JM.  2007.  Use of geographic information systems for planning HIV prevention interventions for high-risk youths.. Am J Public Health. 97(11):1974-81.
Belzer ME, Naar-King S, Olson J, Sarr M, Thornton S, Kahana SY, Gaur AH, Clark LF.  2014.  The use of cell phone support for non-adherent HIV-infected youth and young adults: an initial randomized and controlled intervention trial.. AIDS Behav. 18(4):686-96.
Hightow-Weidman LB, Muessig K, Rosenberg E, Sanchez T, LeGrand S, Gravens L, Sullivan PS.  2018.  University of North Carolina/Emory Center for Innovative Technology (iTech) for Addressing the HIV Epidemic Among Adolescents and Young Adults in the United States: Protocol and Rationale for Center Development.. JMIR Res Protoc. 7(8):e10365.
K Amico R, Dunlap A, Dallas R, Lindsey J, Heckman B, Flynn P, Lee S, Horvath K, Goolsby RWest, Hudgens M et al..  2019.  Triggered Escalating Real-Time Adherence Intervention to Promote Rapid HIV Viral Suppression Among Youth Living With HIV Failing Antiretroviral Therapy: Protocol for a Triggered Escalating Real-Time Adherence Intervention.. JMIR Res Protoc. 8(3):e11416.
K Amico R, Dunlap A, Dallas R, Lindsey J, Heckman B, Flynn P, Lee S, Horvath K, Goolsby RWest, Hudgens M et al..  2019.  Triggered Escalating Real-Time Adherence Intervention to Promote Rapid HIV Viral Suppression Among Youth Living With HIV Failing Antiretroviral Therapy: Protocol for a Triggered Escalating Real-Time Adherence Intervention.. JMIR Res Protoc. 8(3):e11416.
Gilliam PP, Ellen JM, Leonard L, Kinsman S, Jevitt CM, Straub DM.  2011.  Transition of adolescents with HIV to adult care: characteristics and current practices of the adolescent trials network for HIV/AIDS interventions.. J Assoc Nurses AIDS Care. 22(4):283-94.
Wilson EC, Garofalo R, Harris RD, Herrick A, Martinez M, Martinez J, Belzer M.  2009.  Transgender female youth and sex work: HIV risk and a comparison of life factors related to engagement in sex work.. AIDS Behav. 13(5):902-13.
Harper GW, Jadwin-Cakmak LA, Popoff E, Campbell BAnne, Granderson R, Wesp LM.  2019.  Transgender and Other Gender-Diverse Youth's Progression Through the HIV Continuum of Care: Socioecological System Barriers.. AIDS Patient Care STDS. 33(1):32-43.
Kohn JN, Loop MShane, Kim-Chang JJ, Garvie PA, Sleasman JW, Fischer B, H Rendina J, Woods SPaul, Nichols SL, Hong S.  2021.  Trajectories of Depressive Symptoms, Neurocognitive Function, and Viral Suppression With Antiretroviral Therapy Among Youth With HIV Over 36 months.. J Acquir Immune Defic Syndr. 87(2):851-859.
Gamarel KE, Westfall AO, Lally MA, Hosek S, Wilson CM.  2018.  Tobacco Use and Sustained Viral Suppression in Youth Living with HIV.. AIDS Behav. 22(6):2018-2025.
Bauermeister JA, Golinkoff JM, Lin WY, Claude KF, Horvath KJ, Dowshen N, Schlupp A, Vickroy WJ, Desir K, Lopez AV et al..  2019.  Testing the Testers: Are Young Men Who Have Sex With Men Receiving Adequate HIV Testing and Counseling Services? J Acquir Immune Defic Syndr. 82 Suppl 2(2):S133-S141.
Naar S, MacDonell K, Chapman JE, Todd L, Gurung S, Cain D, Dilones RE, Parsons JT.  2019.  Testing a Motivational Interviewing Implementation Intervention in Adolescent HIV Clinics: Protocol for a Type 3, Hybrid Implementation-Effectiveness Trial.. JMIR Res Protoc. 8(6):e11200.
Kim-Chang JJ, Wilson L, Chan C, Fischer B, Venturi G, Goodenow MM, Aldrovandi G, Weber TJ, Sleasman JW.  2019.  Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy.. AIDS Res Hum Retroviruses. 35(8):746-754.
Havens PL, Long D, Schuster GU, Gordon CM, Price G, Wilson CM, Kapogiannis BG, Mulligan K, Stephensen CB.  2018.  Tenofovir disoproxil fumarate appears to disrupt the relationship of vitamin D and parathyroid hormone.. Antivir Ther. 23(7):623-628.
Carballo-Diéguez A, Giguere R, Dolezal C, Chen BA, Kahn J, Zimet G, Mabragaña M, Leu C-S, McGowan I.  2012.  "Tell Juliana": acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study.. AIDS Behav. 16(7):1761-74.
Brennan J, Kuhns LM, Johnson AK, Belzer M, Wilson EC, Garofalo R.  2012.  Syndemic theory and HIV-related risk among young transgender women: the role of multiple, co-occurring health problems and social marginalization.. Am J Public Health. 102(9):1751-7.
Williams JC, Zhang X, Karki M, Chi Y-Y, Wallet SM, Rudy BJ, Nichols SL, Goodenow MM, Sleasman JW.  2018.  Soluble CD14, CD163, and CD27 biomarkers distinguish ART-suppressed youth living with HIV from healthy controls.. J Leukoc Biol. 103(4):671-680.
Mullins TLKowalczy, Li SX, Bethel J, Goodenow MM, Hudey S, Sleasman JW.  2018.  Sexually transmitted infections and immune activation among HIV-infected but virally suppressed youth on antiretroviral therapy.. J Clin Virol. 102:7-11.
Wilson EC, Garofalo R, D Harris R, Belzer M.  2010.  Sexual risk taking among transgender male-to-female youths with different partner types.. Am J Public Health. 100(8):1500-5.
Boyer CB, Greenberg L, Korelitz J, Harper GW, Stewart-Campbell R, Straub D, Sanders R, Reid L-H, Futterman D, Lee S et al..  2019.  Sexual Partner Characteristics, Relationship Type, and HIV Risk Among a Community Venue-based Sample of Urban Adolescent and Young Adult Men Who Have Sex with Men.. Youth Soc. 51(2):219-246.
Keizur EM, Goldbeck C, Vavala G, Romero-Espinoza A, Ocasio M, Fournier J, Lee S-J, Abdalian S-E, Rotheram MJane, Klausner JD.  2020.  Safety and Effectiveness of Same-Day Chlamydia trachomatis and Neisseria gonorrhoeae Screening and Treatment Among Gay, Bisexual, Transgender, and Homeless Youth in Los Angeles, California, and New Orleans, Louisiana.. Sex Transm Dis. 47(1):19-23.
Kahn JA, Xu J, Zimet GD, Liu N, Gonin R, Dillard ME, Squires K.  2012.  Risk perceptions after human papillomavirus vaccination in HIV-infected adolescents and young adult women.. J Adolesc Health. 50(5):464-70.
M Fernández I, Huszti HC, Wilson PA, Kahana S, Nichols S, Gonin R, Xu J, Kapogiannis BG.  2015.  Profiles of Risk Among HIV-Infected Youth in Clinic Settings.. AIDS Behav. 19(5):918-30.
Kahn JA, Rudy BJ, Xu J, Kapogiannis B, Secord E, Gillison M.  2016.  Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.. J Med Virol. 88(11):1944-52.
Kahn JA, Burk RD, Squires KE, Kapogiannis BG, Rudy B, Xu J, Gonin R, Liu N, Worrell C, Wilson CM.  2012.  Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination.. J Acquir Immune Defic Syndr. 61(3):390-9.
Gamarel KE, Brown L, Kahler CW, M Fernández I, Bruce D, Nichols S.  2016.  Prevalence and correlates of substance use among youth living with HIV in clinical settings.. Drug Alcohol Depend. 169:11-18.
Kahn JA, Belzer M, Chi X, Lee J, Gaur AH, Mayer K, Martinez J, Futterman DC, Stier EA, Paul ME et al..  2019.  Pre-vaccination prevalence of anogenital and oral human papillomavirus in young HIV-infected men who have sex with men.. Papillomavirus Res. 7:52-61.
Kahn JA, Belzer M, Chi X, Lee J, Gaur AH, Mayer K, Martinez J, Futterman DC, Stier EA, Paul ME et al..  2019.  Pre-vaccination prevalence of anogenital and oral human papillomavirus in young HIV-infected men who have sex with men.. Papillomavirus Res. 7:52-61.
Robles G, Sauermilch D, Gandhi M, Starks TJ.  2021.  PrEP Demonstration Project Showed Superior Adherence with Tenofovir Alafenamide/Emtricitabine Compared to Tenofovir Disoproxil Fumarate/Emtricitabine in a Sample of Partnered Sexual Minority Men.. AIDS Behav. 25(4):1299-1305.
Baker Z, Javanbakht M, Mierzwa S, Pavel C, Lally M, Zimet G, Gorbach P.  2018.  Predictors of Over-Reporting HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Young Men Who Have Sex With Men (YMSM) in Self-Reported Versus Biomarker Data.. AIDS Behav. 22(4):1174-1183.
Gross IMoses, Hosek S, Richards MHeather, M Fernández I.  2016.  Predictors and Profiles of Antiretroviral Therapy Adherence Among African American Adolescents and Young Adult Males Living with HIV.. AIDS Patient Care STDS. 30(7):324-38.
Siegler AJ, C Mehta C, Mouhanna F, Giler RMera, Castel A, Pembleton E, Jaggi C, Jones J, Kramer MR, McGuinness P et al..  2020.  Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.. Ann Epidemiol. 45:24-31.e3.
Gamarel KE, Darbes LA, Kutsa O, Hightow-Weidman LB, Sullivan P, Stephenson R.  2021.  Perspectives from Young Partnered Gay, Bisexual, and Other Men Who Have Sex with Men on the Adaptation of Couples HIV Testing and Counseling (CHTC).. AIDS Behav. 25(3):836-846.
Stephenson R, Darbes LA, Rosso MT, Washington C, Hightow-Weidman L, Sullivan P, Gamarel KE.  2022.  Perceptions of Contexts of Intimate Partner Violence Among Young, Partnered Gay, Bisexual and Other Men Who Have Sex With Men in the United States.. J Interpers Violence. 37(15-16):NP12881-NP12900.
van den Berg JJ, Javanbakht M, Gorbach PM, Rudy BJ, Westfall AO, Wilson CM, Lally MA.  2018.  Partner Notification for Youth Living With HIV in 14 Cities in the United States.. J Acquir Immune Defic Syndr. 77(1):46-52.
Wilson EC, Iverson E, Garofalo R, Belzer M.  2012.  Parental support and condom use among transgender female youth.. J Assoc Nurses AIDS Care. 23(4):306-17.
Man OM, Ramos WE, Vavala G, Goldbeck C, Ocasio MA, Fournier J, Romero-Espinoza A, M Fernández I, Swendeman D, Lee S-J et al..  2021.  Optimizing Screening for Anorectal, Pharyngeal, and Urogenital Chlamydia trachomatis and Neisseria gonorrhoeae Infections in At-Risk Adolescents and Young Adults in New Orleans, Louisiana and Los Angeles, California, United States.. Clin Infect Dis. 73(9):e3201-e3209.
Zlotorzynska M, Bauermeister JA, Golinkoff JM, Lin W, Sanchez TH, Hightow-Weidman L.  2021.  Online recruitment of youth for mHealth studies.. Mhealth. 7:27.
Nichols SL, Bethel J, Garvie PA, Patton DE, Thornton S, Kapogiannis BG, Ren W, Major-Wilson H, Puga A, Woods SP.  2013.  Neurocognitive functioning in antiretroviral therapy-naïve youth with behaviorally acquired human immunodeficiency virus.. J Adolesc Health. 53(6):763-71.
Yu XG, Lichterfeld M, Chetty S, Williams KL, Mui SK, Miura T, Frahm N, Feeney ME, Tang Y, Pereyra F et al..  2007.  Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes.. J Virol. 81(4):1619-31.
Yu XG, Lichterfeld M, Chetty S, Williams KL, Mui SK, Miura T, Frahm N, Feeney ME, Tang Y, Pereyra F et al..  2007.  Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes.. J Virol. 81(4):1619-31.
Bauermeister JA, Golinkoff JM, Horvath KJ, Hightow-Weidman LB, Sullivan PS, Stephenson R.  2018.  A Multilevel Tailored Web App-Based Intervention for Linking Young Men Who Have Sex With Men to Quality Care (Get Connected): Protocol for a Randomized Controlled Trial.. JMIR Res Protoc. 7(8):e10444.
Giguere R, Zimet GD, Kahn JA, Dolezal C, Leu C-S, Mabragaña M, McGowan I, Carballo-Diéguez A.  2013.  The Motivations and Experiences of Young Women in a Microbicide Trial in the USA and Puerto Rico.. World J AIDS. 3(3)
Knopf AS, Gilbert ALewis, Zimet GD, Kapogiannis BG, Hosek SG, J Fortenberry D, Ott MA.  2017.  Moral conflict and competing duties in the initiation of a biomedical HIV prevention trial with minor adolescents.. AJOB Empir Bioeth. 8(3):145-152.
Gamarel KE, Nelson KM, Heinze J, Chiaramonte DM, Miller RL.  2019.  The moderating role of resilience resources in the association between crime exposure and substance use among young sexual minority men.. Subst Use Misuse. 54(11):1787-1798.
Neilan AM, Bangs AC, Hudgens M, Patel K, Agwu AL, Bassett IV, Gaur AH, Hyle EP, Crespi CM, Horvath KJ et al..  2021.  Modeling Adherence Interventions Among Youth with HIV in the United States: Clinical and Economic Projections.. AIDS Behav. 25(9):2973-2984.
Neilan AM, Patel K, Agwu AL, Bassett IV, K Amico R, Crespi CM, Gaur AH, Horvath KJ, Powers KA, H Rendina J et al..  2019.  Model-Based Methods to Translate Adolescent Medicine Trials Network for HIV/AIDS Interventions Findings Into Policy Recommendations: Rationale and Protocol for a Modeling Core (ATN 161).. JMIR Res Protoc. 8(4):e9898.
Siegler AJ, Knox J, Bauermeister JA, Golinkoff J, Hightow-Weidman L, Scott H.  2021.  Mobile app development in health research: pitfalls and solutions.. Mhealth. 7:32.
Skeen SJ, Cain D, Gamarel KE, Hightow-Weidman L, Reback CJ.  2021.  mHealth for transgender and gender-expansive youth: harnessing gender-affirmative cross-disciplinary innovations to advance HIV prevention and care interventions.. Mhealth. 7:37.
Hosek SG, Green KR, Siberry G, Lally M, Balthazar C, Serrano PA, Kapogiannis B.  2013.  Integrating Behavioral HIV Interventions into Biomedical Prevention Trials with Youth: Lessons from Chicago's Project PrEPare.. J HIV AIDS Soc Serv. 12(3-4)
Naar S, Hudgens MG, Brookmeyer R, Carcone AIdalski, Chapman J, Chowdhury S, Ciaranello A, W Comulada S, Ghosh S, Horvath KJ et al..  2019.  Improving the Youth HIV Prevention and Care Cascades: Innovative Designs in the Adolescent Trials Network for HIV/AIDS Interventions.. AIDS Patient Care STDS. 33(9):388-398.
Murphy DA, Hoffman D, Seage GR, Belzer M, Xu J, Durako SJ, Geiger M.  2007.  Improving comprehension for HIV vaccine trial information among adolescents at risk of HIV.. AIDS Care. 19(1):42-51.
Carcone AIdalski, Coyle K, Gurung S, Cain D, Dilones RE, Jadwin-Cakmak L, Parsons JT, Naar S.  2019.  Implementation Science Research Examining the Integration of Evidence-Based Practices Into HIV Prevention and Clinical Care: Protocol for a Mixed-Methods Study Using the Exploration, Preparation, Implementation, and Sustainment (EPIS) Model.. JMIR Res Protoc. 8(5):e11202.
Bansal A, Yue L, Conway J, Yusim K, Tang J, Kappes J, Kaslow RA, Wilson CM, Goepfert PA.  2007.  Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.. AIDS. 21(18):2387-97.
Kahn JA, Xu J, Kapogiannis BG, Rudy B, Gonin R, Liu N, Wilson CM, Worrell C, Squires KE.  2013.  Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women.. Clin Infect Dis. 57(5):735-44.
Rudy BJ, Kapogiannis BG, Worrell C, Squires K, Bethel J, Li S, Wilson CM, Agwu A, Emmanuel P, Price G et al..  2015.  Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061.. J Acquir Immune Defic Syndr. 69(1):52-60.
Turnbull EL, A Lopes R, Jones NA, Cornforth D, Newton P, Aldam D, Pellegrino P, Turner J, Williams I, Wilson CM et al..  2006.  HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently.. J Immunol. 176(10):6130-46.
Kapogiannis BG, Koenig LJ, Xu J, Mayer KH, Loeb J, Greenberg L, Monte D, Banks-Shields M, J Fortenberry D.  2020.  The HIV Continuum of Care for Adolescents and Young Adults Attending 13 Urban US HIV Care Centers of the NICHD-ATN-CDC-HRSA SMILE Collaborative.. J Acquir Immune Defic Syndr. 84(1):92-100.
Kim-Chang JJ, Donovan K, Loop MShane, Hong S, Fischer B, Venturi G, Garvie PA, Kohn J, H Rendina J, Woods SP et al..  2019.  Higher soluble CD14 levels are associated with lower visuospatial memory performance in Youth with HIV (YWH).. AIDS.
Kim-Chang JJ, Donovan K, Loop MShane, Hong S, Fischer B, Venturi G, Garvie PA, Kohn J, H Rendina J, Woods SP et al..  2019.  Higher soluble CD14 levels are associated with lower visuospatial memory performance in Youth with HIV (YWH).. AIDS.
Bansal A, Gough E, Ritter D, Wilson C, Mulenga J, Allen S, Goepfert PA.  2006.  Group M-based HIV-1 Gag peptides are frequently targeted by T cells in chronically infected US and Zambian patients.. AIDS. 20(3):353-60.
Bansal A, Gough E, Ritter D, Wilson C, Mulenga J, Allen S, Goepfert PA.  2006.  Group M-based HIV-1 Gag peptides are frequently targeted by T cells in chronically infected US and Zambian patients.. AIDS. 20(3):353-60.
Dark T, Simpson KN, Gurung S, Pennar AL, Chew M, Naar S.  2022.  Feasibility of Using Electronic Health Records for Cascade Monitoring and Cost Estimates in Implementation Science Studies in the Adolescent Trials Network for HIV/AIDS Interventions.. JMIR Form Res. 6(4):e25483.
Boyer CB, Greenberg L, Chutuape K, Walker B, Monte D, Kirk J, Ellen JM.  2017.  Exchange of Sex for Drugs or Money in Adolescents and Young Adults: An Examination of Sociodemographic Factors, HIV-Related Risk, and Community Context.. J Community Health. 42(1):90-100.
Ellen JM, Greenberg L, Willard N, Korelitz J, Kapogiannis BG, Monte D, Boyer CB, Harper GW, Henry-Reid LM, Friedman LB et al..  2015.  Evaluation of the effect of human immunodeficiency virus-related structural interventions: the connect to protect project.. JAMA Pediatr. 169(3):256-63.
Ellen JM, Greenberg L, Willard N, Korelitz J, Kapogiannis BG, Monte D, Boyer CB, Harper GW, Henry-Reid LM, Friedman LB et al..  2015.  Evaluation of the effect of human immunodeficiency virus-related structural interventions: the connect to protect project.. JAMA Pediatr. 169(3):256-63.
Lally M, Goldsworthy R, Sarr M, Kahn J, Brown L, Peralta L, Zimet G.  2014.  Evaluation of an intervention among adolescents to reduce preventive misconception in HIV vaccine clinical trials.. J Adolesc Health. 55(2):254-9.
Castillo-Mancilla J, Seifert S, Campbell K, Coleman S, McAllister K, Zheng J-H, Gardner EM, Liu A, Glidden DV, Grant R et al..  2016.  Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.. Antimicrob Agents Chemother. 60(11):6692-6697.
Castillo-Mancilla J, Seifert S, Campbell K, Coleman S, McAllister K, Zheng J-H, Gardner EM, Liu A, Glidden DV, Grant R et al..  2016.  Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.. Antimicrob Agents Chemother. 60(11):6692-6697.
Castillo-Mancilla J, Seifert S, Campbell K, Coleman S, McAllister K, Zheng J-H, Gardner EM, Liu A, Glidden DV, Grant R et al..  2016.  Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.. Antimicrob Agents Chemother. 60(11):6692-6697.
Hill BJ, Motley DN, Rosentel K, VandeVusse A, Garofalo R, Schneider JA, Kuhns LM, Kipke MD, Reisner S, Rupp BM et al..  2020.  An Employment Intervention Program (Work2Prevent) for Young Men Who Have Sex With Men and Transgender Youth of Color (Phase 1): Protocol for Determining Essential Intervention Components Using Qualitative Interviews and Focus Groups.. JMIR Res Protoc. 9(8):e16384.
Hill BJ, Motley DN, Rosentel K, VandeVusse A, Fuller C, Bowers SME, Williams M, Kipke M, Kuhns L, Pashka N et al..  2022.  Employment as HIV Prevention: An Employment Support Intervention for Adolescent Men Who Have Sex With Men and Adolescent Transgender Women of Color.. J Acquir Immune Defic Syndr. 91(1):31-38.
Hill BJ, Motley DN, Rosentel K, VandeVusse A, Fuller C, Bowers SME, Williams M, Kipke M, Kuhns L, Pashka N et al..  2022.  Employment as HIV Prevention: An Employment Support Intervention for Adolescent Men Who Have Sex With Men and Adolescent Transgender Women of Color.. J Acquir Immune Defic Syndr. 91(1):31-38.
Brown LK, Kennard BD, Emslie GJ, Mayes TL, Whiteley LB, Bethel J, Xu J, Thornton S, Tanney MR, Hawkins LA et al..  2016.  Effective Treatment of Depressive Disorders in Medical Clinics for Adolescents and Young Adults Living With HIV: A Controlled Trial.. J Acquir Immune Defic Syndr. 71(1):38-46.
Harper GW, Tyler ATimmons, Bruce D, Graham L, Wade RM.  2016.  Drugs, Sex, and Condoms: Identification and Interpretation of Race-Specific Cultural Messages Influencing Black Gay and Bisexual Young Men Living with HIV.. Am J Community Psychol. 58(3-4):463-476.
Gamarel KE, Darbes LA, Hightow-Weidman L, Sullivan P, Stephenson R.  2019.  The Development and Testing of a Relationship Skills Intervention to Improve HIV Prevention Uptake Among Young Gay, Bisexual, and Other Men Who Have Sex With Men and Their Primary Partners (We Prevent): Protocol for a Randomized Controlled Trial.. JMIR Res Protoc. 8(1):e10370.
Kennard B, Brown L, Hawkins L, Risi A, Radcliffe J, Emslie G, Mayes T, King J, Foxwell A, Buyukdura J et al..  2014.  Development and Implementation of Health and Wellness CBT for Individuals with Depression and HIV.. Cogn Behav Pract. 21(2):237-246.
Liu A, Coleman K, Bojan K, Serrano PAlonso, Oyedele T, Garcia A, Enriquez-Bruce E, Emmanuel P, Jones J, Sullivan P et al..  2019.  Developing a Mobile App (LYNX) to Support Linkage to HIV/Sexually Transmitted Infection Testing and Pre-Exposure Prophylaxis for Young Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial.. JMIR Res Protoc. 8(1):e10659.
Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Liu N et al..  2017.  Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.. Clin Infect Dis. 64(3):317-325.
Ellen JM, Greenberg L, Willard N, Stines S, Korelitz J, Boyer CB.  2015.  Cross-sectional survey comparing HIV risk behaviours of adolescent and young adult men who have sex with men only and men who have sex with men and women in the U.S. and Puerto Rico.. Sex Transm Infect. 91(6):458-61.
Gamarel KE, Nichols S, Kahler CW, Westfall AO, Lally MA, Wilson CM.  2018.  A cross-sectional study examining associations between substance use frequency, problematic use and STIs among youth living with HIV.. Sex Transm Infect. 94(4):304-308.
K Amico R, Crawford J, Ubong I, Lindsey JC, Gaur AH, Horvath K, Goolsby R, Johnson MMueller, Dallas R, Heckman B et al..  2021.  Correlates of High HIV Viral Load and Antiretroviral Therapy Adherence Among Viremic Youth in the United States Enrolled in an Adherence Improvement Intervention.. AIDS Patient Care STDS. 35(5):145-157.
K Amico R, Crawford J, Ubong I, Lindsey JC, Gaur AH, Horvath K, Goolsby R, Johnson MMueller, Dallas R, Heckman B et al..  2021.  Correlates of High HIV Viral Load and Antiretroviral Therapy Adherence Among Viremic Youth in the United States Enrolled in an Adherence Improvement Intervention.. AIDS Patient Care STDS. 35(5):145-157.
Simoni JM, Tapia K, Lee S-J, Graham SM, Beima-Sofie K, Mohamed ZH, Christodoulou J, Ho R, Collier AC.  2020.  A Conjoint Analysis of the Acceptability of Targeted Long-Acting Injectable Antiretroviral Therapy Among Persons Living with HIV in the U.S.. AIDS Behav. 24(4):1226-1236.
Nichols SL, Lowe A, Zhang X, Garvie PA, Thornton S, Goldberger BA, Hou W, Goodenow MM, Sleasman JW.  2014.  Concordance between self-reported substance use and toxicology among HIV-infected and uninfected at risk youth.. Drug Alcohol Depend. 134:376-382.
Nichols SL, Lowe A, Zhang X, Garvie PA, Thornton S, Goldberger BA, Hou W, Goodenow MM, Sleasman JW.  2014.  Concordance between self-reported substance use and toxicology among HIV-infected and uninfected at risk youth.. Drug Alcohol Depend. 134:376-382.
Nichols SL, Lowe A, Zhang X, Garvie PA, Thornton S, Goldberger BA, Hou W, Goodenow MM, Sleasman JW.  2014.  Concordance between self-reported substance use and toxicology among HIV-infected and uninfected at risk youth.. Drug Alcohol Depend. 134:376-382.
Boyer CB, Robles-Schrader GM, Li SX, Miller RL, Korelitz J, Price GN, Torres CMRivera, Chutuape KS, Stines SJ, Straub DM et al..  2014.  A comparison of network-based strategies for screening at-risk Hispanic/Latino adolescents and young adults for undiagnosed asymptomatic HIV infection.. J Adolesc Health. 55(6):765-73.
Koss CA, Hosek SG, Bacchetti P, Anderson PL, Liu AY, Horng H, Benet LZ, Kuncze K, Louie A, Saberi P et al..  2018.  Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States.. Clin Infect Dis. 66(2):213-219.
Lee S-J, Ocasio MA, Goldbeck CS, Koussa M, Comulada WScott, Swendeman D, Klausner JD, Rotheram-Borus MJane.  2020.  Community-based Implementation of Centers for Disease Control and Prevention's Recommended Screening for Sexually Transmitted Infections Among Youth at High Risk for HIV Infection in Los Angeles and New Orleans.. Sex Transm Dis. 47(7):481-483.

Pages